21/11/2026

Health Ministry Proposes Central Approval for Antimicrobial Manufacturing Licen…

The Union health ministry has proposed an amendment to the New Drugs and Clinical Trials Rules, 2019, requiring antimicrobial manufacturers to obtain central permission before applying for state manufacturing licences. The draft notification, G.S.R. 983(E) dated November 6, aims to classify antimicrobials as 'new drugs,' enhancing regulatory oversight. This change addresses concerns over inadequate scrutiny of antimicrobial products, which could worsen antibiotic resistance. The proposal is part of broader efforts to ensure the quality, safety, and efficacy of these products and to promote responsible antimicrobial use. Stakeholders and the public have 30 days to submit objections and suggestions before finalisation.

Published 1 day ago • 20 Nov 2026, 07:58 AM IST

Sources